The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty

被引：1
作者：
Shao, Long [1 ]
Wu, Xiang-Dong [2 ]
机构：
[1] Ningbo 6 Hosp, Dept Orthopaed Surg, Ningbo, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100730, Peoples R China
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷 / 05期
关键词：
D O I：
10.1002/jbmr.3983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：998 / 999
页数：2
相关论文
共 15 条
  • [1] Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial
    Anastasilakis, Athanasios D.
    Papapoulos, Socrates E.
    Polyzos, Stergios A.
    Appelman-Dijkstra, Natasha M.
    Makras, Polyzois
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (12) : 2220 - 2228
  • [2] Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty
    Aro, Hannu T.
    Nazari-Farsani, Sanaz
    Vuopio, Mia
    Loyttyniemi, Eliisa
    Mattila, Kimmo
    [J]. JBMR PLUS, 2019, 3 (10)
  • [3] Periprosthetic Bone Remodeling Using a Triple-Taper Polished Cemented Stem in Total Hip Arthroplasty
    Buck, Aaron J.
    Dowsey, Michelle M.
    Stoney, James D.
    Hardidge, Andrew J.
    Ng, Kong Wah
    Choong, Peter F. M.
    [J]. JOURNAL OF ARTHROPLASTY, 2010, 25 (07) : 1083 - 1090
  • [4] Effects and management of denosumab discontinuation
    Chapurlat, Roland
    [J]. JOINT BONE SPINE, 2018, 85 (05) : 515 - 517
  • [5] Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
    Huang, Tsan-Wen
    Wang, Chao-Jan
    Shih, Hsin-Nung
    Chang, Yuhan
    Huang, Kuo-Chin
    Peng, Kuo-Ti
    Lee, Mel S.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [6] Observations following discontinuation of long-term denosumab therapy
    McClung, M. R.
    Wagman, R. B.
    Miller, P. D.
    Wang, A.
    Lewiecki, E. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1723 - 1732
  • [7] Denosumab Prevents Early Periprosthetic Bone Loss After Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial
    Nystrom, Andreas
    Kiritopoulos, Demostenis
    Ullmark, Gosta
    Sorensen, Jens
    Petren-Mallmin, Marianne
    Milbrink, Jan
    Hailer, Nils P.
    Mallmin, Hans
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (02) : 239 - 247
  • [8] Lower periprosthetic bone loss and good fixation of an ultra-short stem compared to a conventional stem in uncemented total hip arthroplasty A randomized clinical trial with DXA and RSA in 51 patients
    Salemyr, Mats
    Muren, Olle
    Ahl, Torbjorn
    Boden, Henrik
    Eisler, Thomas
    Stark, Andre
    Skodenberg, Olof
    [J]. ACTA ORTHOPAEDICA, 2015, 86 (06) : 659 - 666
  • [9] The Effect of Weekly Risedronate on Periprosthetic Bone Resorption Following Total Hip Arthroplasty A Randomized, Double-Blind, Placebo-Controlled Trial
    Skoldenberg, Olof Gustaf
    Salemyr, Mats Olof
    Boden, Henrik Stefan
    Ahl, Torbjorn Efraim
    Adolphson, Per Yngve
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2011, 93A (20) : 1857 - 1864
  • [10] Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
    Tsourdi, Elena
    Langdahl, Bente
    Cohen-Solal, Martine
    Aubry-Rozier, Berengere
    Eriksen, Erik Fink
    Guanabens, Nuria
    Obermayer-Pietsch, Barbara
    Ralston, Stuart H.
    Eastell, Richard
    Zillikens, M. Carola
    [J]. BONE, 2017, 105 : 11 - 17
12